Total Payments
$4,561
2024 Payments
$735.88
Companies
28
Transactions
169
Medicare Patients
7,535
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$4,308 (94.5%)
Consulting$212.50 (4.7%)
Education$39.95 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,308 | 166 | 94.5% |
| Consulting Fee | $212.50 | 2 | 4.7% |
| Education | $39.95 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,066 | 29 | $0 (2024) |
| Allergan, Inc. | $800.73 | 38 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $655.77 | 33 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $250.73 | 9 | $0 (2021) |
| Shire North American Group Inc | $248.67 | 4 | $0 (2019) |
| Oyster Point Pharma, Inc. | $158.36 | 7 | $0 (2024) |
| Genentech USA, Inc. | $150.65 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $130.35 | 6 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $124.41 | 1 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $103.59 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.88 | 27 | Bausch & Lomb Americas Inc. ($174.46) |
| 2023 | $833.40 | 28 | Bausch & Lomb Americas Inc. ($305.05) |
| 2022 | $430.22 | 24 | Bausch & Lomb Americas Inc. ($176.26) |
| 2021 | $357.56 | 15 | Allergan, Inc. ($113.57) |
| 2020 | $208.81 | 12 | Allergan, Inc. ($122.52) |
| 2019 | $697.80 | 28 | Allergan Inc. ($243.00) |
| 2018 | $885.45 | 22 | Regeneron Healthcare Solutions, Inc. ($410.96) |
| 2017 | $411.74 | 13 | Allergan Inc. ($144.44) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Dry eyes | ||||||
| 11/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $67.55 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/03/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Ophthalmology | ||||||
| 08/20/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $68.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/20/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Ophthalmology | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $35.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Dry eyes | ||||||
| 06/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Dry eyes | ||||||
| 06/03/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Ophthalmology | ||||||
| 05/16/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/10/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Ophthalmology | ||||||
| 04/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: EYE CARE | ||||||
| 03/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $37.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/06/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,974 | 3,453 | $2.7M | $634,056 |
| 2022 | 16 | 1,787 | 3,151 | $2.6M | $622,697 |
| 2021 | 15 | 1,860 | 3,609 | $2.2M | $756,666 |
| 2020 | 16 | 1,914 | 3,362 | $1.6M | $580,992 |
Total Patients
7,535
Total Services
13,575
Medicare Billing
$2.6M
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 55 | 656 | $2.1M | $448,916 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 374 | 443 | $62,020 | $33,952 | 54.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 64 | 358 | $179,000 | $31,294 | 17.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 300 | 304 | $56,240 | $25,554 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 379 | $37,900 | $22,823 | 60.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 30 | 45 | $112,500 | $17,398 | 15.5% |
| 92134 | Imaging of retina | Office | 2023 | 309 | 614 | $52,190 | $17,078 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $20,196 | $10,025 | 49.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 29 | 38 | $34,200 | $8,777 | 25.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 154 | 163 | $18,908 | $6,489 | 34.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 192 | 197 | $16,745 | $4,568 | 27.3% |
| J3590 | Unclassified biologics | Office | 2023 | 15 | 46 | $5,520 | $3,173 | 57.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 20 | 20 | $4,400 | $1,810 | 41.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 35 | 51 | $10,200 | $1,467 | 14.4% |
| 92025 | Ct scan of cornea | Office | 2023 | 24 | 25 | $1,375 | $636.62 | 46.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 11 | 12 | $480.00 | $95.37 | 19.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 54 | 630 | $2.0M | $449,165 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 364 | 440 | $61,600 | $35,807 | 58.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 68 | 348 | $174,000 | $30,086 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 339 | $33,900 | $20,158 | 59.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 266 | 268 | $49,580 | $19,603 | 39.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 34 | 46 | $115,000 | $18,662 | 16.2% |
| 92134 | Imaging of retina | Office | 2022 | 294 | 530 | $45,050 | $14,905 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $14,454 | $7,782 | 53.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 20 | 26 | $23,400 | $6,652 | 28.4% |
About Dr. Sally Primus, MD
Dr. Sally Primus, MD is a Ophthalmology healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1114292208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sally Primus, MD has received a total of $4,561 in payments from pharmaceutical and medical device companies, with $735.88 received in 2024. These payments were reported across 169 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,308).
As a Medicare-enrolled provider, Primus has provided services to 7,535 Medicare beneficiaries, totaling 13,575 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Evansville, IN
- Active Since 03/21/2012
- Last Updated 11/18/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114292208
Products in Payments
- EYLEA (Biological) $565.25
- EYLEA AFLIBERCEPT INJECTION (Biological) $500.99
- LUMIGAN (Drug) $405.51
- XIIDRA (Drug) $284.99
- VYZULTA (Drug) $277.14
- DURYSTA (Drug) $218.72
- MIEBO (Drug) $166.52
- TYRVAYA (Drug) $158.36
- LOTEMAX SM (Drug) $154.04
- Vabysmo (Drug) $150.65
- RESTASIS (Drug) $142.91
- Tecnis 1-piece IOL (Device) $124.41
- ACTHAR (Biological) $113.74
- Fanapt (Drug) $103.59
- PURIFIED CORTROPHIN GEL (Drug) $96.22
- Cequa (Drug) $75.39
- EYLEA HD (Biological) $74.77
- TEPEZZA (Biological) $74.47
- PROLENSA (Drug) $51.67
- rhopressa (Drug) $49.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Evansville
Dr. Omar Dukar, M.d, M.D
Ophthalmology — Payments: $80,119
Ophthalmology $80,119
Dr. Dwight Silvera, Md, MD
Ophthalmology — Payments: $23,953
Ophthalmology $23,953
Dr. David Malitz, M.d, M.D
Ophthalmology — Payments: $16,931
Ophthalmology $16,931
Andrew Strand, D.o, D.O
Ophthalmology — Payments: $13,577
Ophthalmology $13,577
Dr. Gregory Hayden, Md, MD
Ophthalmology — Payments: $12,121
Ophthalmology $12,121
Dr. Matthew Boyer, Md, MD
Ophthalmology — Payments: $6,901
Ophthalmology $6,901